Inventor · disambiguated record
Falko-Guenter Falkner
Also filed as: FALKNER FALKO G · FALKNER FALKO-GUENTER · FALKNER FALKO-GÜENTER
18 granted patents·2 pending applications·481 citations·filing 1995–2011
96Inventor score
Top patents by PatentIndex Score
20 records- 0195US7033590B1Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2000·Granted Apr 25, 2006·47 cites·22 claims
- 0290US7279161B2Factor IX/factor IXa activating antibodies and antibody derivativesBAXTER AG·Filed 2005·Granted Oct 9, 2007·6 cites·9 claims
- 0387US5854403AMethod for isolation of highly pure von Willebrand FactorIMMUNO AG·Filed 1996·Granted Dec 29, 1998·53 cites·16 claims
- 0486US6114146AExpression plasmid, a fusion protein, a transfected eukaryotic cell line, a method of producing foreign proteins, a foreign protein preparation as well as a pharmaceutical compositionBAXTER AG·Filed 1995·Granted Sep 5, 2000·94 cites·31 claims
- 0583US6210929B1Fusion protein comprising a furin derivative or a derivative of a furin analogue and a heterologous sequenceBAXTER AG·Filed 1996·Granted Apr 3, 2001·43 cites·22 claims
- 0682US6905846B2Nucleic acids encoding factor X deletion mutants and analogues thereofBAXTER AG·Filed 2003·Granted Jun 14, 2005·15 cites·17 claims
- 0779US7998488B2Vaccine formulations and uses thereofBAXTER INT·Filed 2008·Granted Aug 16, 2011·4 cites·18 claims
- 0876US9884105B2Production of viral vaccineKISTNER OTFRIED·Filed 2009·Granted Feb 6, 2018·2 cites·23 claims
- 0974US6103693AMethod for isolation of highly pure von willebrand factorBAXTER AG·Filed 1997·Granted Aug 15, 2000·27 cites·13 claims
- 1073US5858658AMethod of quantitating genomic DNAIMMUNO AG·Filed 1995·Granted Jan 12, 1999·52 cites·23 claims
- 1172US7025970B2Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methodsBAXTER HEATHCARE S A·Filed 2003·Granted Apr 11, 2006·8 cites·14 claims
- 1272US6562598B1Factor X deletion mutants and analogues thereofBAXTER AG·Filed 1998·Granted May 13, 2003·27 cites·56 claims
- 1372US5880265AMethod for isolation of highly pure von willebrand factorIMMUNO AG·Filed 1997·Granted Mar 9, 1999·22 cites·7 claims
- 1471US8753648B2Modified poxviruses, including modified smallpox virus vaccine based on recombinant drug-sensitive vaccinia virus, and new selection methodsFALKNER FALKO-GUENTER·Filed 2005·Granted Jun 17, 2014·1 cites·14 claims
- 1571US5789153AMethod of quantitating nucleic acidIMMUNO AG·Filed 1995·Granted Aug 4, 1998·48 cites·28 claims
- 1669US8795683B2Vaccine formulations and uses thereofOBERREITHER MANFRED·Filed 2011·Granted Aug 5, 2014·3 cites·18 claims
- 1765US5877152AMethod for isolation of highly pure von Willebrand FactorIMMUNO AG·Filed 1997·Granted Mar 2, 1999·14 cites·9 claims
- 1860US6352856B1Chimeric poxvirus comprising sequences of a retroviral vector componentBAXTER VACCINE AG·Filed 1999·Granted Mar 5, 2002·15 cites·15 claims
- 1947US2002019350A1Targeted angiogenesisFiled 2001·Application pending·0 cites
- 2037US2011159031A1Vaccine to Influenza A VirusBAXTER INT·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Falko-Guenter Falkner files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →